A MDS evidence‐based review on treatments for Huntington's Disease

© 2021 International Parkinson and Movement Disorder Society Background: Huntington's disease (HD) is a rare neurodegenerative disorder with protean clinical manifestations. Its management is challenging, consisting mainly of off-label treatments. Objectives: The International Parkinson and Mov...

Full description

Saved in:

Bibliographic Details
Published in:	Movement disorders Vol. 37; no. 1; pp. 25 - 35
Main Authors:	Ferreira, Joaquim J, Rodrigues, Filipe Brogueira, Duarte, Gonçalo, Mestre, Tiago, Bachoud‐Levi, Anne‐Catherine, Bentivoglio, Anna Rita, Burgunder, Jean‐Marc, Cardoso, Francisco, Claassen, Daniel O., Landwehrmeyer, G. Bernard, Kulisevsky, Jaime, Nirenberg, Melissa J., Rosser, Anne, Roth, Jan, Seppi, Klaus, Slawek, Jaroslaw, Furr‐Stimming, Erin, Tabrizi, Sarah J., Walker, Francis O., Vandenberghe, Wim, Costa, João, Sampaio, Cristina
Format:	Journal Article
Language:	English
Published:	Hoboken, USA Wiley 01-01-2022 John Wiley & Sons, Inc Wiley Subscription Services, Inc
Subjects:	Apathy Chorea Clinical trials Drug therapy Dystonia Emotional behavior evidence‐based medicine GRADE approach Humans Huntingtin Huntington Disease - drug therapy Huntington Disease - therapy Huntington's disease Huntingtons disease Movement disorders Movement Disorders - drug therapy Neurodegenerative diseases Psychosis Tetrabenazine Tetrabenazine - therapeutic use Therapeutic applications Vesicular monoamine transporter 2 GRADE approach drug therapy Huntington's disease evidence-based medicine
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!